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ABSTRACT
Our working hypothesis was that synthesis and release of LH, but not FSH, were solely dependent on LHRH. Twenty ovari-
ectomized (OVX) ewes were randomly assigned to one of five treatments (n = 4 per group). Ewes were administered a low
(10 pg/kg) or high (100 g/kg) dose of LHRH antagonist (LHRH-Ant) at 24-h intervals for 3 or 6 days. Control ewes received
vehicle (5% mannitol) at 24-h intervals for 6 days. Blood samples were collected every 15 min for 4 h before LHRH-Ant or
vehicle and every 2 h during the period of treatment to determine concentrations of LH and FSH. Twenty-four hours after the
last treatment with LHRH-Ant or vehicle, anterior pituitaries were collected and divided in half along the midsagittal plane; the
number of receptors for LHRH, pituitary content of LH and FSH, and relative amounts of mRNA for ca, LHI1, and FSHP subunits
were determined. Concentrations of LH in serum decreased (p < 0.05) from 25.4 ± 4.3 ng/ml before LHRH-Ant to less than
0.5 ng/ml within 4 h after the first treatment of LHRH-Ant and remained low (< 0.5 ng/ml) throughout the study. Serum
concentrations of FSH declined gradually during the 3- or 6-day period of treatment with LHRH-Ant, from 37.3 ± 2.4 and 26.5
± 4.8 ng/ml to 19.9 1.8 and 13.7 ± 2.1 ng/ml, respectively. The magnitude of decline in serum concentrations of LH and
FSH did not differ among ewes treated with low or high doses of LHRH-Ant. Pituitary content of LH was not different (p > 0.10)
from that in controls, whereas pituitary content of FSH was greater (p < 0.01) in control ewes compared to ewes treated with
LHRH-Ant. Receptors for LHRH were nondetectable (< 0.018 x 10-16 mol receptor/tg protein) in pituitaries after 3 or 6 days
of treatment with LHRH-Ant (low or high dose). Relative amounts of mRNA for a, LHII, and FSHP subunits were lower (p <
0.01) after 6 days of treatment with LHRH-Ant (low or high dose) than after 3 days of treatment with LHRH-Ant (low or high
dose). The LHRH was, therefore, required to maintain steady state amounts of mRNA for FSH and LH and to maintain pituitary
stores of FSH but not LH. Our data support the hypothesis that differential regulation of LH and FSH release occurs in ewes.
While synthesis and release of LH are dependent on LHRH, synthesis but not release of FSH appears to be dependent on LHRH.
INTRODUCTION
After characterization of LHRH, it was widely accepted
that LHRH not only stimulates release of LH, but also FSH,
from gonadotrophs of the anterior pituitary [1]. There are
some reports suggesting that factors other than LHRH may
regulate release of FSH [2-5]. The role of LHRH in mod-
ulation of the release of FSH was questioned because de-
creased stimulation of the pituitary resulted in a greater de-
crease in release of LH than in release of FSH.
One method of studying the physiology of the isolated
pituitary gland is to actively immunize ovariectomized ewes
against LHRH to abolish the specific hypothalamic input. In
ovariectomized ewes immunized against LHRH, it has been
reported that the release of both LH and FSH is markedly
reduced [6].
Another method to isolate the pituitary from the influ-
ence of the hypothalamus is to perform the surgical pro-
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cedure of hypothalamic-pituitary disconnection. In sheep,
hypothalamic-pituitary disconnection leaves the primary
blood supply (superior hypophyseal arteries) to the pars
distalis intact, while the pituitary gland remains viable and
functions independently of hypothalamic input [7]. After hy-
pothalamic-pituitary disconnection in ovariectomized ewes,
pituitary and serum concentrations of LH and FSH as well
as amounts of mRNA for the subunits of gonadotropins were
reported to decline within 3 days [4].
A third method for studying the physiology of the pi-
tuitary is through the use of antagonists against LHRH. Syn-
thetic LHRH antagonists inhibit gonadotropin release by oc-
cupation of LHRH receptors on gonadotrophs [5, 8-10]. Use
of LHRH antagonists is advantageous to hypothalamic-pi-
tuitary disconnection because only LHRH inputs are blocked,
leaving the rest of the hypothalamic-pituitary axis intact. The
objective of the present study was to use an LHRH antag-
onist to determine the role of LHRH in the regulation of
synthesis and release of LH and FSH in ovariectomized ewes.
MATERIALS AND METHODS
Twenty crossbred ovariectomized ewes were randomly
assigned to one of five groups for treatment with either a
low (10 g/kg) or a high (100 Vzg/kg) dose of an LHRH
755
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TABLE 1. Concentrations of anterior pituitary receptors for LHRH.
Receptor concentrations
Treatment (10-16 mol/ptg protein)
Control 1.36 ± 0 .44
d
Ant-3Low NDc
Ant-3Higha ND
Ant-6Lowb ND
Ant-6Highb ND
aLow (10 pLg/kg) or High (100 pg/kg) concentration of LHRH-antagonist for
3 days.
bLow (10 Lg/kg) or High (100 g/kg) concentration of LHRH-antagonist for
6 days.
'ND = Nondetectable, <0.018 x 10-'6 mol receptor/pig protein.
dMean ± SEM.
antagonist (LHRH-Ant). The antagonist used in this study
was [N-Ac-D-Nal(2)'-4CI-D-Phe2 , D-Pal(3)3-D-Cit6, D-Ala'O]-
LHRH (SB-75). The LHRH-Ant was dissolved in 5% manni-
tol, and 1 ml was administered s.c. Ewes received the low
or high dose of LHRH-Ant every 24 h for 3 (n = 4; Ant-
3Low and Ant-3High, respectively) or 6 days (n = 4; Ant-
6Low and Ant-6High, respectively). Ewes in the control group
received sham injections (1 ml 5% mannitol) every 24 h
for 6 days. In sheep, the low concentration of LHRH-Ant (10
Rg/kg) had been shown previously to suppress release of
LH for 24 h when administered s.c. [11]. The high concen-
tration of LHRH-Ant (100 g/kg) was used to ensure that
all receptors to LHRH would be occupied.
Blood samples were collected every 2 h from 4 h before
the initiation of treatment until 24 h after the last injection.
Blood was allowed to clot at room temperature and stored
at 4°C for 12 h; serum was then separated by centrifugation
at 1500 x g for 15 min. Serum was stored at -20°C until
assayed for LH and FSH.
Quantitation of LH [12] and FSH [13, 14] in serum and
pituitaries was by RIA. Intraassay coefficients of variation
were 4.3 and 4.2%, and interassay coefficients of variation
were 11.1 and 9.7% for LH and FSH, respectively.
Twenty-four hours after the last treatment with LHRH-
Ant, animals were administered 4 ml of phenobarbital to
achieve general anesthesia. Anterior pituitary glands were
collected immediately after exsanguination, divided in half
along the midsagittal plane, and stored at -70°C until sub-
sequent analysis. Half of each anterior pituitary gland was
used to measure receptors for LHRH [15] and pituitary con-
tent of LH and FSH as described above. The remaining half
of each anterior pituitary gland was used to measure steady
state amounts of mRNA for ao and LHi subunits [16], and a
similar procedure was followed for FSHP subunit. The re-
maining half of each pituitary gland was used to isolate total
cellular RNA as described previously [4,16]. Five micro-
grams of total cellular RNA from individual hemipituitaries
was separated by electrophoresis through 1.5% agarose gels
containing formaldehyde and transferred to nylon mem-
branes (Zeta-Probe GT; Bio-Rad Labs., Hercules, CA).
Radioactive cDNA probes for bovine a subunit [17], bo-
vine LHI subunit [18], bovine FSH3 subunit [19], or rat cy-
clophilin [20] were prepared by random-primed labeling
[21]. Specific activity of all radioactive cDNA probes was ap-
proximately 2 x 109 dpm/,ig. Radioactive cDNA probes (106
cpm/ml; 10 ml/nylon membrane) were hybridized to total
cellular RNA on nylon membranes for at least 24 h at 42°C
and washed; specific radiolabeled bands were visualized by
autoradiography for 24-96 h at -70 0C [4]. The relative den-
sity of each band was quantitated by scanning densitometry
with a Visage 110 image analyzer (Eastman Kodak, Roch-
ester, NY). Relative amounts of mRNA for gonadotropin
subunits were normalized to relative amounts of cyclo-
philin mRNA to correct for unequal loading of RNA [16].
Values are expressed as percentage of those measured in
ovariectomized, control ewes (ovariectomized = 100%).
Concentrations of LH and FSH in circulation before and
after treatment with LHRH-Ant, pituitary contents of LH and
FSH, and relative amounts of mRNA for gonadotropin sub-
units were examined by analysis of variance using the gen-
eral linear models procedure of the SAS program [22]. Dif-
ferences between treatment means were determined by
Fisher's least significant difference test [22, 23].
RESULTS
Receptors for LHRH in anterior pituitary glands were
nondetectable (< 0.018 x 10- 16 mol receptor/g protein)
after 3 or 6 days of treatment with LHRH-Ant (either low
or high dose). Control ewes had 1.31 + 0.44 x 10-16 mol
receptor/,ig protein (Table 1).
With both the low and high doses of LHRH-Ant, concen-
trations of LH in serum decreased (p < 0.01) from an av-
erage of 25.4 + 4.3 ng/ml before administration of LHRH-
Ant to less than 2.0 ng/ml within 8 h after the first treat-
ment of LHRH-Ant (Fig. 1). Concentrations of LH remained
low (< 0.5 ng/ml) throughout the period (3 or 6 days) of
treatment (Table 2).
Concentrations of FSH in serum declined gradually, to
44% of the original concentration, in ewes from the Ant-
3Low and Ant-3High groups (Fig. 1). Similarly, there was a
52% decrease in concentrations of FSH in ewes treated with
low or high concentrations of LHRH-Ant for 6 days. The
magnitude of decline in serum concentrations of FSH did
not differ among ewes treated with the low vs. the high
dose of LHRH-Ant. Concentrations of FSH in serum after 3
or 6 days of treatment with LHRH-Ant were lower (p <
0.01) than in controls. Pituitary content (mg/pituitary) of
LH was not different (p > 0.05) in ewes treated with LHRH-
Ant compared to control ewes. Amounts of LH were, how-
ever, greater (p < 0.05) in ewes from the Ant-6Low (1.54
+ 0.44) group than in those from the Ant-6High group (0.71
+ 0.10). Pituitary content (mg/pituitary) of FSH was greater
(p < 0.01) in controls (0.75 - 0.25) than in ewes from the
Ant-3Low (0.13 ± 0.02), Ant-3High (0.19 ± 0.06), Ant-6Low
(0.14 - 0.04), and Ant-6High (0.14 - 0.04) groups (Fig. 2).
Steady state amounts of mRNA for a and LH subunits
were different (p < 0.01) among all treatment groups and
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FIG. 1. Concentrations of LH and FSH during administration of LHRH
antagonist or vehicle. The top panel depicts mean concentrations of serum
FSH in control ewes (dashed line, OVX) and ewes in the Ant-6High group
(solid line). Mean concentrations of LH are depicted in the bottom panel
for control ewes (dashed line, OVX) and ewes in the Ant-6High group (solid
line). Ewes in the Ant-6 group were treated with 100 jwg/kg LHRH-Ant at
24-h intervals for 6 days.
were dose- and time-dependent (a: 36.33, 29.16, 18.25, and
12.13% of control for Ant-3Low, Ant-3High, Ant-6Low,
and Ant-6High groups, respectively; LH[:70.17, 68.37, 29.76,
and 25.50% of control for Ant-3Low, Ant-3High, Ant-6Low,
and Ant-6High, respectively). Amounts of mRNA for FSHP3
subunit were lower (p < 0.01) in pituitaries from all treat-
ment groups compared to controls. Amounts of mRNA for
FSH[ also decreased in a dose- and time-dependent man-
ner (79.59, 60.64, 67.10, and 36.04% of control for Ant-3Low,
Ant-3High, Ant-6Low, and Ant-6High treatments, respec-
tively, Fig. 3).
DISCUSSION
Effects of LHRH on synthesis and release of LH and FSH
were examined by administering a low (10 Lg/kg) or a
high (100 g/kg) dose of LHRH-Ant for 3 or 6 days. The
low dose of LHRH-Ant had been previously used to sup-
press release of LH in wethers [11].
Receptors for LHRH were below the level of assay de-
tection in ewes treated with either dose of LHRH-Ant in the
present study. The LHRH-Ant, SB-75, binds to a population
of high-affinity receptors for LHRH in membranes of pitui-
taries [24, 25]. Binding of SB-75 to receptors for LHRH in
pituitaries might influence the rate of turnover of the plasma
membrane [26] and the rate of internalization of LHRH re-
ceptors [27]. Prolonged treatment with SB-75 (60 days) was
reported to result in down-regulation of LHRH receptors in
FIG. 2. Pituitary content (mg/pituitary) of LH and FSH. Ant-3Low and
Ant-3High groups received 10 and 100 g/kg of LHRH antagonist for 3 days,
respectively. Ant-6Low and Ant-6High groups received 10 and 100 i±g/kg
of antagonist for 6 days, respectively. Control ewes received vehicle (1 ml
of 5% mannitol). a,b) Bars with different letters differ (p < 0.05).
anterior pituitary tissue [26]. Treatment with SB-75 in the
present study might have caused a down-regulation of LHRH
receptors that further resulted in a decreased stimulation
of gonadotrophs by endogenous LHRH. Consequently,
changes in amounts of mRNA for gonadotropin subunits,
content of pituitary gonadotropins, and concentrations of
gonadotropins in circulation can be explained by changes
in populations of LHRH receptors available to bind endog-
enous LHRH. Alternatively, LHRH receptors might have been
present in the plasma membranes of gonadotrophs but not
available to bind iodinated LHRH in the radioreceptor assay
because they were occupied by antagonist.
Release of LH was reduced to less than 2 ng/ml ap-
proximately 8 h after treatment with LHRH-Ant, and re-
mained low throughout the treatment period. As a result
FIG. 3. Amounts of mRNA for a, LH[, and FSHP subunits. Values are
expressed as percentage of controls. Ant-3Low and Ant-3High groups re-
ceived 10 and 100 pLg/kg of LHRH antagonist for 3 days, respectively. Ant-
6Low and Ant-6High groups received 10 and 100 g/kg of antagonist for
6 days, respectively. Control ewes received vehicle (1 ml of 5% mannitol).
a,b,c) Bars with different letters differ (p < 0.01).
, - t.: 6A :'o t o'°' .,- o "
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TABLE 2. Serum concentrations of LH and FSH (ng/ml) before and after treatment with LHRH-Ant.
Treatment LH beforea LH afterb FSH before FSH afterb
Control 14.7 + 1.2 13.62 + 3.13C 39.3 - 9.0 40.0 + 8.9c
Ant-3Low 20.1 + 6.8 0.35 + 0 .15 d 28.9 2.0 21.0 1.2
Ant-3Highe 22.0 + 2.5 0.20 + 0.11 d 37.3 3.0 22.8 ± 3 7d
Ant-6Low f 26.7 + 5.9 0.37 + 0.13 d 31.1 + 2.0 17.0 + 2.2d
Ant-6Highf 12.4 + 1.3 0.30 0.09d 27.6 + 3.0 13.8 4.1d
aSamples were collected every 15 min for 4 h before initiation of treatments with LHRH-antagonist or vehicle (Mean
± SEM).
bMean over a 10-h period (2-h samples starting 14 h after last treatment with LHRH-antagonist or vehicle).
c.dDifferent letters within the same column differ (p < 0.01).
eLow (10 ig/kg) or High (100 g/kg) concentration of LHRH-antagonist every 24 h for 3 days.
'Low (10 g/kg) or High (100 pg/kg) concentration of LHRH-antagonist every 24 h for 6 days.
of decreased LHRH stimulation of the gonadotrophs, sup-
pressed release of LH was also reported in ovariectomized
rats [5] and intact male rats [2, 28] in which LHRH was im-
munoneutralized with ovine LHRH antisera and [29] in men
[30] and postmenopausal women [8] treated with an LHRH
antagonist. Continued release of LH, therefore, appears to
be dependent upon LHRH stimulation.
In contrast to LH, serum concentrations of FSH de-
creased only approximately 50% in the present study. A
similar observation was reported in male rats after admin-
istration of LHRH antagonist [2, 5, 28], in rats in which LHRH
was immunoneutralized with an ovine LHRH antiserum [29],
and in men [30] and postmenopausal women treated with
LHRH antagonist [8]. Basal release of FSH, therefore, ap-
pears to be only partially dependent upon stimulation by
LHRH.
Pituitary content of LH did not differ among animals
treated with LHRH-Ant compared to controls. In contrast,
pituitary content of FSH was reduced in all ewes treated
with LHRH. It is hypothesized that the decrease in pituitary
stores of FSH resulted from continued release of FSH. In
contrast, there was a 98% decrease in LH release, allowing
maintenance of pituitary stores of LH. Apparently, endog-
enous LHRH in ewes from the Ant-6High group was max-
imally decreased and the ewes responded to LHRH-Ant
treatment similarly to ewes with hypothalamic-pituitary dis-
connection [31].
A reduction in steady state amounts of mRNA for ct and
LH3 subunits occurred after treatment with LHRH-Ant in
the present investigation. A similar decrease in amounts of
a and LH3 subunits was observed previously in rats after
treatment with an antagonist of LHRH [5] and in hypotha-
lamic-pituitary-disconnected ewes [4]. Amounts of mRNA for
FSHi subunit differed in ewes treated with LHRH-Ant com-
pared to control ewes but were not decreased to the same
extent as ct and LH3 subunits. The reduction in steady state
amounts of mRNA for subunits of gonadotropins leads to
the suggestion that gonadotroph function requires contin-
ued inputs from the hypothalamus. Previous work [32] also
indicated that a pulsatile pattern of LHRH was needed to
stimulate transcription of gonadotropin subunit genes.
It has been hypothesized that factors other than LHRH
regulate the release of FSH [2-4,33]. Chronic inhibition of
pulsatile release of LHRH in intact ewes during the breed-
ing season was reported to suppress amounts of FSH[3 sub-
unit mRNA and release of FSH by 30 to 50%, but amounts
of LHP subunit mRNA and LH release were suppressed by
greater than 95% compared to control values [34]. Admin-
istration of LHRH antisera into the median eminence for 30
h failed to influence release of FSH but reduced release of
LH [35]. A single treatment of anestrous ewes with ovine
follicular fluid caused an initial suppression of FSH release
that was not affected by the acute blockade of LHRH [36].
It was suggested that a component of FSH release is in-
dependent of LHRH but that the subsequent enhanced re-
lease of FSH that follows this initial suppression may have
a component that is LHRH-dependent. The present exper-
iment indicates that LHRH is necessary for synthesis of FSH
in ewes. Release of FSH appeared to decline only in as-
sociation with decreased stores of FSH in the pituitary and
does not appear to be entirely dependent on LHRH. Our
data support the hypothesis that differential regulation of
LH and FSH release occurs in sheep. However, LHRH seems
to be required for maintenance of steady state amounts of
mRNA for the subunits of both pituitary gonadotropins.
ACKNOWLEDGMENTS
We thank Deb Clopton and Ken Pearson for their technical assistance with lab-
oratory analysis and also Robin Hopper for manuscript preparation; Dr. Gautam Sar-
ath and the Peptide Synthesis Facility of the Center for Biotechnology, University of
Nebraska, Lincoln, for synthesis of the antagonist; and Dr. AV. Schally for expertise
regarding antagonist use. We also thank Dr. Leo Reichert for purified FSH and LH,
Dr. Jim Dias for FSH antisera, and Dr. Richard Maurer for cDNA clones.
REFERENCES
1. Schally AV, Arimura A, Kastin AJ, Matsuo H, Baba Y, Redding TW, Nair RMG,
Debeljuk L, White RF. Gonadotropin-releasing hormone: one polypeptide reg-
ulates secretion of luteinizing and follicle-stimulating hormones. Science 1971;
173:1036-1038.
2. Kartun K, Schwartz NB. Effects of a potent antagonist to gonadotropin-releasing
hormone on male rats: luteinizing hormone is suppressed more than follicle-
stimulating hormone. Biol Reprod 1987; 36:103-108.
3. Culler MD, Negro-Vilar A Evidence that pulsatile follicle-stimulating hormone
secretion is independent of endogenous luteinizing hormone-releasing hor-
mone. Endocrinology 1986; 118:609-612.
758
SYNTHESIS AND RELEASE OF LH AND FSH
4. Hamernik DL, Crowder ME, Nilson JH, Nett TM. Measurement of messenger ri-
bonucleic acid for luteinizing hormone -subunit, a-subunit, growth hormone,
and prolactin after hypothalamic pituitary disconnection in ovariectomized ewes.
Endocrinology 1986; 119:2704-2710.
5. Wierman ME, Rivier JE, Wang C. Gonadotropin-releasing hormone-dependent
regulation of gonadotropin subunit messenger ribonudeic acid levels in the rat.
Endocrinology 1989; 124:272-278.
6. Adams TE, Adams BM. Gonadotrope function in ovariectomized ewes actively
immunized against gonadotropin-releasing hormone (GnRH). Biol Reprod 1986;
35:360-367.
7. Clarke IJ, Cummins JT, de Kretser DM. Pituitary gland function after disconnec-
tion from direct hypothalamic influences in the sheep. Neuroendocrinology 1983;
36:376-384.
8. Davis MR, Veldhuis JD, Rogol AD, Dufau ML, Catt KJ. Sustained inhibitory actions
of a potent antagonist of gonadotropin-releasing hormone in postmenopausal
women. J Clin Endocrinol & Metab 1987; 64:1268-1274.
9. Pavlou SN, Wakefield GB, Island DP, Hoffman PG, LePage ME, Chan RL, Neren-
bergand CA, Kovacs WJ. Suppression of pituitary-gonadal function by a potent
new luteinizing hormone-releasing hormone antagonist in normal men. J Clirq
Endocrinol & Metab 1987; 64:931-936.
10. Lalloz MR, Detta A, Clayton RN. Gonadotropin-releasing hormone is required for
enhanced luteinizing hormone subunit gene expression in vivo. Endocrinology
1988; 122:1681-1688.
11. Christianson SL, Zalesky DD, Grotjan HE. Acute inhibition of endogenous LH
secretion in sheep: a comparison of four LHRH antagonists. Biol Reprod 1991;
4 4(suppl):82 (Abstract).
12. Zalesky DD, Nett TM, Grotjan HE. Ovine luteinizing hormone: isoforms in the
pituitary during the follicular and luteal phases of the estrous cycle and during
anestrus. J Anim Sci 1992; 70:3851-3856.
13. Acosta B, Tarnavasky GK, Platt TE, Hamernik DL, Brown JL, Schoenenmann HM,
Reeves 1. Nursing enhances the negative effect of estrogen on LH release in the
cow. J Anim Sci 1983; 57:1530-1536.
14. Wolfe MW, Stumpf IT, Roberson MS, Wolfe PL, Kittok RJ, Kinder JE. Estradiol
influences on pattern of gonadotropin secretion in bovine males during period
of changed responses to estradiol feedback in age-matched females. Biol Reprod
1989; 41:626-634.
15. Nett TM, Crowder ME, Moss GE, Duello TM. GnRH-receptor interaction. V. Down
regulation of pituitary receptors for GnRH in ovariectomized ewes by infusion
of homologous hormone. Biol Reprod 1981; 24:1145-1155.
16. Roberson MS, Wolfe MW, Stumpf T, Hamernik DL, Cupp AS, Werth LA, Kojima
N, Kittok RJ, Grotjan HE, Kinder JE. Steady-state amounts of a- and luteinizing
hormone (LH) 3-subunit messenger ribonudeic acids are uncoupled from pul-
satility of LH secretion during sexual maturation of the heifer. Biol Reprod 1992;
46:435-441.
17. Erwin CR, Coyle ML, Donelson JE, Maurer RA Nucleotide sequence of cloned
complementary deoxyribonucleic acid for the a subunit of bovine pituitary gly-
coprotein hormones. Biochemistry 1983; 22:4856-4860.
18. Maurer RA. Analysis of several bovine lutropin ,8 subunit cDNAs reveals heter-
ogeneity in nucleotide sequence. J Biol Chem 1985; 260:4684-4687.
19. Maurer RA, Beck A. Isolation of nucleotide sequence analysis of a cloned cDNA
encoding the 3-subunit of bovine follicle-stimulating hormone. DNA 1986; 5:363-
369.
20. Danielson PE, Forss-Petter S, Brow MA, Calavetta L, Douglass J, Milner RJ, Sutcliffe
JG. plB15: A cDNA clone of the rat mRNA encoding cyclophilin. DNA 1988; 7:261-
267.
21. Feinberg AP, Vogelstein B. A technique for radiolabelling DNA restriction en-
donuclease fragments to high specific activity. Anal Biochem 1983; 132:6.
22. SAS. SAS Users Guide: Statistics. Cary, NC: Statistical Analysis Systems Institute,
Inc.; 1985.
23. Steel RGD, Torrie JH. Principles and Procedures of Statistics, ed. 2. New York:
McGraw-Hill; 1980.
24. Bajusz S, Kovacs M, Gazdag M, Bokser L, Karashima T, Csernus VJ, Janaky T,
GuothJM, Schally AV. Highly potent antagonists of luteinizing hormone-releasing
hormone free of edematogenic effects. Proc Natl Acad Sci USA 1988; 85:1637-
1641.
25. Bajusz S, Csernus VJ, Janaky T, Bokser L, Fekete M, Schally AV. New antagonists
of LH-RH: II. Inhibition and potentiation by closely related analogues. Int J Pept
Protein Res 1988; 32:425-435.
26. Bokser L, Srkalovic G, Szepeshazi K, Schally AV. Recovery of pituitary-gonadal
function in male and female rats after prolonged administration of a potent an-
tagonist of luteinizing hormone-releasing hormone (SB75). Neuroendocrinology
1991; 54:136-145.
27. Hazum E, Conn PM. Molecular mechanism of gonadotropin releasing hormone
(GnRH) action. I. The GnRH receptor. Endocr Rev 1988; 9:379-386.
28. Clayton RN, Channabasavalah K, Stewart JM, Catt KJ. Hypothalamic regulation of
pituitary gonadotropin-releasing hormone receptors: effects of hypothalamic le-
sions and a gonadotropin-releasing hormone antagonist. Endocrinology 1982;
110:1108-1115.
29. Culler MD, Negro-Vilar A Pulsatile follicle-stimulating hormone secretion is in-
dependent of Luteinizing hormone-releasing hormone (LHRH): pulsatile replace-
ment of LHRH bioactivity in LHRH-immunoneutralized rats. Endocrinology 1987;
120:2011-2021.
30. Jockenhovel F, Bhasin S, Steiner BS, Rivier JE, Vale WW, Swerdloff RS. Hormonal
effects of single gonadotropin-releasing hormone antagonist doses in men. J Clin
Endocrinol & Metab 1988; 66:1065-1070.
31. Hamernik DL, Nett TM. Gonadotropin-releasing hormone increases the amount
of messenger ribonucleic acid for gonadotropins in ovariectomized ewes after
hypothalamic-pituitary disconnection. Endocrinology 1988; 122:959-966.
32. Haisenleder DJ, Dalkin AC, Ortolano GA, Marshall JC, Shupnik MA A pulsatile
gonadotropin-releasing hormone stimulus is required to increase transcription
of the gonadotropin subunit genes: evidence for differential regulation of tran-
scription by pulse frequency in vivo. Endocrinology 1991; 128:509-517.
33. Lumpkin MD, DePaolo LV, Negro-Vilar A Pulsatile release of follicle-stimulating
hormone in ovariectomized rats is inhibited by porcine follicular fluid (inhibin).
Endocrinology 1984; 114:201-206.
34. McNeilly JR, Brown P, Clark AJ, McNeilly AS. Gonadotropin releasing hormone
modulation of gonadotrophins in the ewe: evidence for differential effects on
gene expression and hormone secretion. J Mol Endocrinol 1991; 7:35-43.
35. Currie WD, Ellis KA, Gourley SA, Joseph IBJK, Cook SJ, Rawlings NC. Luteinizing
and follicle-stimulating hormone secretion during median eminence perfusion
or intravenous infusion with gonadotrophin-releasing hormone antisera in ovari-
ectomized ewes. Anim Reprod Sci 1993; 31:277-285.
36. Brooks J, Struthers WJ, McNeilly AS. GnRH-dependent and -independent com-
ponents of FSH secretion after acute treatment of anoestrous ewes with ovine
follicular fluid and a GnRH antagonist. J Reprod Fertil 1993; 98:591-595.
759
